Notably, in this study that included only COPD patients, the presence of ILA was inversely associated with the prevalence of lung cancer (OR = 0.50), particularly lung adenocarcinoma (OR = 0.32), a finding discrepant from studies in the general population. Here, TNFRSF9 is linked to lung cancer.